Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

C Schmaltz; O Alpdogan; K J Horndasch; S J Muriglan; B J Kappel; T Teshima; J L Ferrara; S J Burakoff; M R van den Brink

doi:10.1182/blood.v97.9.2886

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

Identifier:nobleid.org/w1/20260515/B15DF8EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B15DF8EB.svg?ark=w1%2F20260515%2FB15DF8EB)](https://nobleid.org/work/w1/20260515/B15DF8EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

Identifier:nobleid.org/w1/20260515/B15DF8EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B15DF8EB.svg?ark=w1%2F20260515%2FB15DF8EB)](https://nobleid.org/work/w1/20260515/B15DF8EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work